• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

East Coast insurer now covers tibial nerve stimulation for OAB

Article

Uroplasty, Inc. has announced that EmblemHealth now covers percutaneous tibial nerve stimulation using the company's Urgent PC Neuromodulation System for the treatment of overactive bladder and associated symptoms.

Uroplasty, Inc. has announced that EmblemHealth now covers percutaneous tibial nerve stimulation using the company’s Urgent PC Neuromodulation System for the treatment of overactive bladder and associated symptoms.

EmblemHealth covers approximately two million lives primarily in New York and New Jersey and includes Group Health Inc. and the Health Plan of New York.

“This expanded private payer coverage increases access for OAB patients to percutaneous tibial nerve stimulation treatments and the opportunity to receive this innovative, minimally invasive, and clinically effective therapy. The additional coverage provides physicians in the Northeast with another treatment option for their OAB patients,” said David Kaysen, president and CEO of Uroplasty.

Related Videos
Jenny Guo, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Samuel L. Washington III, MD, MAS, answers a question during a Zoom video interview
Human kidney cross section on scientific background | © Crystal light - stock.adobe.com
Leo Dreyfuss, MD, answers a question during a Zoom video interview
Neal Shore, MD, FACS, and Brian M. Shuch, MD, experts on kidney cancer
Neal Shore, MD, FACS, and Brian M. Shuch, MD, experts on kidney cancer
© 2024 MJH Life Sciences

All rights reserved.